Aromatherapy in Reducing PONV for Total Joint Replacement Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHong Kong Buddhist Hospital

About this trial

This study investigates the effectiveness of aromatherapy in reducing postoperative nausea and vomiting (PONV) among patients undergoing total joint replacement surgery, as these complications can lead to patient discomfort and prolonged recovery. It is designed as a randomized controlled trial involving 159 participants, who will be divided into three groups: an intervention group receiving aromatherapy patches (lavender-sandalwood or orange-ginger) plus standard care, a placebo group with a placebo patch plus standard care, and a control group receiving standard care alone. PONV will be measured using the Rhodes Index of Nausea, Vomiting, and Retching (RINVR) at baseline, 30 minutes after the intervention, and every 12 hours post-surgery. Additionally, patient satisfaction will be assessed through a 5-point Likert scale survey. The primary outcome of the study is the evaluation of RINVR scores, while the secondary outcome focuses on patient satisfaction levels. Data will be statistically analyzed using two-way ANOVA for repeated measures, with a significance level defined as p \< 0.05. The study aims to determine the viability of aromatherapy as a complementary treatment for PONV, potentially improving postoperative care, enhancing patient satisfaction, and offering a cost-effective alternative to conventional anti emetic treatments if proven effective.

Eligibility criteria

Qualifiers

Adults aged 18 or above

Patients scheduled for total joint replacement surgery at the HKBH

Disqualifiers

Cognitive impairments

Allergy to lavender, orange, ginger, or sandalwood

Allergy to micro-pore tape

Allergy to opioid medication

Trial design

Treatments tested in this trial

  • Aromatherapy patches
  • Placebo Patches
  • Control (Standard treatment)

Treatment groups

159 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Hong Kong Buddhist Hospital

Lead sponsor

Queen Elizabeth Hospital, Hong Kong

Collaborator